genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
06 December 2023
Final Results Presentation 30 June 2023
View all reports >
Monday February 19, 2024
Genedrive eyes funding in aim of NHS recommendation
Wednesday February 03, 2021
Genedrive close to hitting the market with coronavirus tests
Friday December 22, 2023
Week ahead: Housing stats the main interest post-Christmas
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-24 genedrive plc
Don't show this again